These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7793230)

  • 1. Rising mortality from Parkinson's disease in Japan, 1950-1992.
    Imaizumi Y; Kaneko R
    Acta Neurol Scand; 1995 Mar; 91(3):169-76. PubMed ID: 7793230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical variations in mortality from Parkinson's disease in Japan, 1977-1985.
    Imaizumi Y
    Acta Neurol Scand; 1995 May; 91(5):311-6. PubMed ID: 7639057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Gompertzian analysis of Parkinson's disease mortality in Japan, 1950-1993.
    Imaizumi Y
    Mech Ageing Dev; 1995 Nov; 85(1):15-23. PubMed ID: 8789252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and cancer incidence in patients with Parkinson's disease.
    Minami Y; Yamamoto R; Nishikouri M; Fukao A; Hisamichi S
    J Neurol; 2000 Jun; 247(6):429-34. PubMed ID: 10929271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and mortality of Parkinson's disease in older Canadians.
    Allyson Jones C; Wayne Martin WR; Wieler M; King-Jesso P; Voaklander DC
    Parkinsonism Relat Disord; 2012 May; 18(4):327-31. PubMed ID: 22197034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two decades of increasing mortality from Parkinson's disease among the US elderly.
    Lilienfeld DE; Chan E; Ehland J; Godbold J; Landrigan PJ; Marsh G; Perl DP
    Arch Neurol; 1990 Jul; 47(7):731-4. PubMed ID: 2357152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years ago.
    Kusumi M; Nakashima K; Harada H; Nakayama H; Takahashi K
    Neuroepidemiology; 1996; 15(4):201-7. PubMed ID: 8817502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
    Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
    Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of Parkinson's disease in Japan. Tottori University Parkinson's Disease Epidemiology (TUPDE) Study Group.
    Nakashima K; Maeda M; Tabata M; Adachi Y; Kusumi M; Ohshiro H
    Eur Neurol; 1997; 38 Suppl 2():60-3. PubMed ID: 9387805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism death rates by race, sex and geography: a 1980s update.
    Lilienfeld DE; Sekkor D; Simpson S; Perl DP; Ehland J; Marsh G; Chan E; Godbold JH; Landrigan PJ
    Neuroepidemiology; 1990; 9(5):243-7. PubMed ID: 2087248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Gompertzian analysis of Parkinson's disease mortality in the U.S., 1955-1986: the dramatic increase in overall mortality since 1980 is the natural consequence of deterministic mortality dynamics.
    Riggs JE
    Mech Ageing Dev; 1990 Sep; 55(3):221-33. PubMed ID: 2232914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease mortality in Italy, 1951 through 1987. Analysis of an increasing trend.
    Chió A; Magnani C; Tolardo G; Schiffer D
    Arch Neurol; 1993 Feb; 50(2):149-53. PubMed ID: 8431133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality rate of Alzheimer's disease in Japan: secular trends, marital status, and geographical variations.
    Imaizumi Y
    Acta Neurol Scand; 1992 Nov; 86(5):501-5. PubMed ID: 1481632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Parkinson's disease related mortality in England and Wales, 1993-2006.
    Mylne AQ; Griffiths C; Rooney C; Doyle P
    Eur J Neurol; 2009 Sep; 16(9):1010-6. PubMed ID: 19538202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.
    Peretz C; Rozani V; Giladi N; El-Ad B; Tsamir J; Hemo B; Gurevich T
    Neuroepidemiology; 2019; 53(1-2):13-19. PubMed ID: 31203291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can the national burden of Parkinson's disease comorbidity and mortality be estimated for the Japanese population?
    Doi Y; Yokoyama T; Nakamura Y; Nagai M; Fujimoto K; Nakano I
    J Epidemiol; 2011; 21(3):211-6. PubMed ID: 21422700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized mortality ratio and seasonal fluctuations of mortality in Parkinson's disease.
    Hristova DR
    Folia Med (Plovdiv); 2009; 51(2):40-5. PubMed ID: 19670539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in Parkinson's disease-related mortality among males in Northern Italy.
    Fedeli U; Schievano E
    Parkinsonism Relat Disord; 2017 Jul; 40():47-50. PubMed ID: 28416129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of preventive effect of maize on mortality from Parkinson's disease in Japan.
    Fukushima T; Tanaka K; Ushijima K; Moriyama M
    Asia Pac J Clin Nutr; 2003; 12(4):447-50. PubMed ID: 14672869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increase of Parkinson's disease mortality could be due to a cohort effect.
    Chio A; Magnani C; Schiffer D
    Acta Neurol Scand; 1995 Aug; 92(2):113-5. PubMed ID: 7484056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.